Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells

被引:91
作者
Duarte, N
Stenström, M
Campino, S
Bergman, ML
Lundholm, M
Holmberg, D
Cardell, SL [1 ]
机构
[1] Lund Univ, Ctr Biomed I13, Immunol Sect, S-22184 Lund, Sweden
[2] Umea Univ, Dept Med Biosci Med & Clin Genet, Umea, Sweden
[3] Gulbenkian Inst Sci, Oeiras, Portugal
[4] Norrland Univ Hosp, Dept Clin Genet, Umea, Sweden
关键词
D O I
10.4049/jimmunol.173.5.3112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A role for regulatory lymphocytes has been demonstrated in the pathogenesis of type I diabetes in the NOD mouse but the nature of these cells is debated. CD1d-restricted NKT lymphocytes have been implicated in this process. Previous reports of reduced diabetes incidence in NOD mice in which the numbers of NKT cells are artificially increased have been attributed to the enhanced production of IL-4 by these cells and a role for classical NKT cells, using the Valpha14-Jalpha18 rearrangement. We now show that overexpression in NOD mice of CD1d-restricted TCR Valpha3.2(+)Vbeta9(+) NKT cells producing high levels of IFN-gamma but low amounts of IL-4 leads to prevention of type 1 diabetes, demonstrating a role for nonclassical CD1d-restricted NKT cells in the regulation of autoimmune diabetes.
引用
收藏
页码:3112 / 3118
页数:7
相关论文
共 39 条
[1]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[2]   NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells [J].
Beaudoin, L ;
Laloux, V ;
Novak, J ;
Lucas, B ;
Lehuen, A .
IMMUNITY, 2002, 17 (06) :725-736
[3]  
Behar SM, 1999, J IMMUNOL, V162, P161
[4]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[5]   Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1T cells [J].
Bendelac, A ;
Hunziker, RD ;
Lantz, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1285-1293
[6]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[7]   T-CELL-MEDIATED INHIBITION OF THE TRANSFER OF AUTOIMMUNE DIABETES IN NOD MICE [J].
BOITARD, C ;
YASUNAMI, R ;
DARDENNE, M ;
BACH, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1669-1680
[8]   CD1-RESTRICTED CD4(+) T-CELLS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-DEFICIENT MICE [J].
CARDELL, S ;
TANGRI, S ;
CHAN, S ;
KRONENBERG, M ;
BENOIST, C ;
MATHIS, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :993-1004
[9]   The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD [J].
Delovitch, TL ;
Singh, B .
IMMUNITY, 1997, 7 (06) :727-738
[10]   A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus [J].
Falcone, M ;
Yeung, B ;
Tucker, L ;
Rodriguez, E ;
Sarvetnick, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :963-972